PUK2 Issues in the Systematic Review of Drugs for Rare Diseases: A Case Study of Eculizumab for aHUS

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1440
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Puk2 Dutasteride for Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Psy158 - A Pragmatic Literature Review to Identify Economic Outcomes for Repurposed Drugs in Rare Diseases

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Systematic Review of the Potential Herbal Sources of Future Drugs Effective in Oxidant-Related Diseases

Inflammation & Allergy-Drug Targets
2009English

The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases

Medical Decision Making
Health Policy
2014English

Patient-Reported Data Informing Early Benefit Assessment of Rare Diseases in Germany: A Systematic Review

Health Economics Review
Health Policy
2019English

A Rare Case of Langerhans Cell Histiocytosis of the Skull in an Adult: A Systematic Review

Rare Tumors
OncologyHistology
2013English

Gene Therapy for Rare Diseases – The Case for Acute Intermittent Porphyria

EPMA Journal
BiochemistryHealth PolicyDrug Discovery
2014English

A Systematic Review of Techniques for Test Case Prioritization

International Journal of Computer Applications
2013English

A Proposed Definition of Rare Diseases for China: From the Perspective of Return on Investment in New Orphan Drugs

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy